-
1تقرير
المصدر: Evaluating the Efficacy of Artesunate-mefloquine on the Thai-Myanmar Border and the Relative Roles of Resistance Genetic Markers: A Retrospective Cohort Study
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02427360Test
-
2تقرير
المصدر: A Cluster-randomised, Open-label Trial to Compare the Impact of Combined Mass Vaccine and Drug Administrations, Mass Drug Administration, Mass Vaccinations, or no Intervention on Plasmodium Falciparum Malaria Transmission
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06068530Test
-
3تقرير
المصدر: An Open-label, Randomised, Controlled, Non-inferiority Trial to Compare the Efficacy, Safety and Tolerability of a Fixed Dose Triple Artemisinin-based Combination Therapy (TACT) Artemether-lumefantrine-amodiaquine Versus First-line Artemisinin-based Combination Therapies (ACTs) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05951595Test
-
4تقرير
المصدر: Operational Evaluation of Mass Screening and Treatment Using Ultrasensitive Rapid Detection Tests to Reduce P. Falciparum Incidence in a Malaria Elimination Program in Eastern Kayin State, Myanmar
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04093765Test
-
5تقرير
المصدر: A Multi-centre Randomised Controlled Non-inferiority Trial to Compare the Efficacy, Safety and Tolerability of Triple Artemisinin-based Combination Therapies Versus First-line ACTs + Placebo for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Asia
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03939104Test
-
6تقرير
المصدر: A Multi-centre Randomised Controlled Non-inferiority Trial to Compare the Efficacy, Safety and Tolerability of Triple Artemisinin-based Combination Therapies Versus First-line ACTs + Placebo for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Africa
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03923725Test
-
7تقرير
المؤلفون: World Health Organization, NCHADS - Ministry of Health of Cambodia, Mahidol University, Institut Pasteur, FHI 360, Li Ka Shing Foundation
المساهمون: Arjen Dondorp, Deputy Director
المصدر: Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00493363Test
-
8تقرير
المصدر: Randomized Clinical Trial of the Efficacy and Safety of Dihydroartimisinine+Papiraquine (Artekin) Compared With First Line Drugs for Treatment of Vivax and Uncomplicated Falciparum Malaria in Afghanistan
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00682578Test
-
9تقرير
المساهمون: Josh Hanson
المصدر: Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum Malaria
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00692627Test
-
10تقرير
المؤلفون: Mahidol University, Medicines for Malaria Venture
المصدر: Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00936767Test